【结 构 式】 |
【分子编号】30714 【品名】6-(2-oxiranyl)-2-phenyl-4H-[1,3]dioxino[5,4-b]pyridine 【CA登记号】 |
【 分 子 式 】C15H13NO3 【 分 子 量 】255.27316 【元素组成】C 70.58% H 5.13% N 5.49% O 18.8% |
合成路线1
该中间体在本合成路线中的序号:(VI)A new method for the synthesis of pirbuterol hydrochloride has been described: By reaction of 2-phenyl-4H-1,3-dioxino[5,4-b]pyridine-6-carbaldehyde (I) with methyltriphenylphosphonium bromide (II) and NaOH in toluene to give 2-phenyl-6-vinyl-4H-1,3-dioxino[5,4-b]pyridine (III), which is treated with m-chloroperbenzoic acid (IV) in methylene chloride to give 6-(1,2-epoxyethyl)-2-phenyl-4H-1,3-dioxino[5,4-b]pyridine N-oxide (V). Compound (V) can also be obtained from 6-(1,2-epoxyethyl)-2-phenyl-4H-1,3-dioxino[5,4-b]pyridine (VI) by reaction with m-chloroperbenzoic acid (IV) as before. The reaction of (V) with tert-butylamine (VII) in methanol affords 6-(1-hydroxy-2-tert-butylaminoethyl)-2-phenyl-4H-1,3-dioxino[5,4-b]pyridine N-oxide (VIII), which is first treated with H2 over Pd/C in methanol and then with HCl in ethyl acetate to give pirbuterol hydrochloride.
【1】 Masset, S.S.; Cue, B.W. (Pfizer Inc.); Process and intermediates for preparing pirbuteol and analogs. EP 0058069; EP 0058070; EP 0058071; EP 0058072; JP 57150665 . |
中间体序号 | 中间体编号 | 品名 | CAS号 | 分子式 | 供应商 | 用于合成 |
---|---|---|---|---|---|---|
(I) | 30711 | 2-phenyl-4H-[1,3]dioxino[5,4-b]pyridine-6-carbaldehyde | C14H11NO3 | 详情 | 详情 | |
(II) | 30484 | Methyl(triphenyl)phosphonium bromide | 1779-49-3 | C19H18BrP | 详情 | 详情 |
(III) | 30712 | 2-phenyl-6-vinyl-4H-[1,3]dioxino[5,4-b]pyridine | C15H13NO2 | 详情 | 详情 | |
(V) | 30713 | 6-(2-oxiranyl)-2-phenyl-4H-[1,3]dioxino[5,4-b]pyridin-5-ium-5-olate | C15H13NO4 | 详情 | 详情 | |
(VI) | 30714 | 6-(2-oxiranyl)-2-phenyl-4H-[1,3]dioxino[5,4-b]pyridine | C15H13NO3 | 详情 | 详情 | |
(VII) | 17895 | 2-Amino-2-methylpropane; tert-butylamine; 2-methyl-2-propanamine | 75-64-9 | C4H11N | 详情 | 详情 |
(VIII) | 30715 | 6-[2-(tert-butylamino)-1-hydroxyethyl]-2-phenyl-4H-[1,3]dioxino[5,4-b]pyridin-5-ium-5-olate | C19H24N2O4 | 详情 | 详情 |